News from the Greater Southern California Node

Upcoming Telehealth (TH) & Telemedicine (TM) Special Interest Group (SIG) on 09/13/2024 @ 8:30am PT/11:30am ET (see flyer attached for additional information)

• Presenters:
  • Darren Urada, PhD, UCLA
  • Thomas Freese, PhD, UCLA
• Webinar description:
  • More than half of individuals admitted for specialty substance use disorder treatment in California identify stimulants as their primary or secondary drug, yet many people who use stimulants do not seek treatment. Numerous studies have shown that contingency management (CM) is the most effective treatment for stimulant use disorder. California’s innovative Recovery Incentives Program is a groundbreaking initiative that benefits California and serves as a potential blueprint for other states. In this webinar, Drs. Freese and Urada will delve into the program’s achievements and challenges by providing an overview of the Program, and preliminary quantitative and qualitative evaluation findings.  Presenters will talk about the connection to technology and the potential for telehealth implementation in the future. Time will be provided for Q&A and discussion with the audience. 
  • The presentation will be recorded and will be posted to the CTN Library as soon as it is available.

Publication announcements:  

• Lin, C., Cousins, S. J., Zhu, Y., Clingan, S. E., Mooney, L. J., Kan, E., Wu, F., & Hser, Y. (2024). A scoping review of social determinants of health’s impact on substance use disorders over the life course. Journal of Substance Use and Addiction Treatment, 166, 209484. (doi: 10.1016/j.josat.2024.209484)

• Flores, J. M., Kan, E., Mooney, L. J., Pham, H., Zhu, Y., Wolitzky-Taylor, K., & Hser, Y. (2024). Medications for opioid use disorder among transition age youth compared to adults 26 or older in rural settings. JAACAP Open. (doi: 10.1016/j.jaacop.2024.02.001)

• Kan, E., Baldwin, L. M., Mooney, L. J., Saxon, A. J., Zhu, Y., & Hser, Y. I. (2024). Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder. Journal of substance use and addiction treatment, 164, 209339. (doi: 1016/j.josat.2024.209339)
  • Note: Developed with support and in collaboration with the Pacific Northwest Node

• Calhoun, S., Guo, H., Fei, Z., Lin, C., Clingan, S. E., Zhu, Y., Mooney, L. J., & Hser, Y. (2024). Impact of COVID-19 on MOUD retention in a sample of rural primary care patients: A secondary analysis of electronic health records. Drug and Alcohol Dependence Reports, 12, 100276. (doi: 10.1016/j.dadr.2024.100276)